Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2015 | 08-2014 | 06-2014 | 08-2013 | 06-2013 | |
| Sales | 262 | 1 | 59 | 2 | 2 |
| Cost of Goods | 88 | N/A | N/A | N/A | 0 |
| Gross Profit | 174 | 1 | 59 | 2 | 2 |
| Operating Expenses | 7,894 | 59 | 6,406 | 54 | 54 |
| Operating Income | -7,632 | -58 | -6,347 | -52 | -52 |
| Interest Expense | 115 | 4 | 46 | 5 | 5 |
| Pre-tax Income | -7,747 | -62 | -6,392 | -57 | -57 |
| Income Tax | -24 | N/A | -814 | N/A | 0 |
| Net Income Continuous | -7,723 | -62 | -5,579 | -57 | -57 |
| Net Income | $-7,723 | $-62 | $-5,579 | $-57 | $-57 |
| EPS Basic Total Ops | -805,599.90 | -0.01 | -0.80 | -0.01 | -0.12 |
| EPS Basic Continuous Ops | -805,227.90 | -0.01 | -0.80 | -0.01 | -0.14 |
| EPS Diluted Total Ops | -805,599.90 | -0.01 | -0.80 | -0.01 | -0.12 |
| EPS Diluted Continuous Ops | -805,227.90 | -0.01 | -0.80 | -0.01 | -0.14 |
| EBITDA(a) | $-7,392 | $-53 | $-6,214 | $-48 | $-48 |